Clincosm LogoSign in Get a demo

Circulating Levels of Pealbumin in Relation to Overweight or Obesity

Sponsor
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis (Other)
Overall Status
Completed
CT.gov ID
NCT04333446
Collaborator
(none)
84
Enrollment
1
Location
11.8
Actual Duration (Months)
7.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The study was aimed to investigating the relationship between circulating level of prealbumin and parathormone (PTH), triglycerides and triiodothyronine (FT3) in overweight and obese subjects (BMI≥25 Kg/m2)

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    84 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Independent Relationship Between Prealbumin and Circulating Levels of Parathormone Triglycerides and FT3 in Subjects With Overweight or Obesity
    Actual Study Start Date :
    Jan 7, 2019
    Actual Primary Completion Date :
    Jul 26, 2019
    Actual Study Completion Date :
    Dec 31, 2019

    Outcome Measures

    Primary Outcome Measures

    1. Prealbumin [baseline]

      Prealbumin (g/L) concentration in serum

    2. Free Triiodothyronine (FT3) [baseline]

      FT3 (pg/mL) concentration in serum

    3. Parathormone (PTH) [baseline]

      PTH (pg/mL) concentration in serum

    4. Triglycerides [baseline]

      Triglycerides (mg/dl) concentration in serum

    Secondary Outcome Measures

    1. Height [baseline]

      Height in meters

    2. Weight [baseline]

      Weight in kilograms

    3. Body mass Index (BMI) [baseline]

      BMI (kg/m^2)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Overweight or obesity (BMI> 25 Kg/m2)
    Exclusion Criteria:
    • Any kind of drug Hypertension Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), Chronic inflammatory diseases Renal failure Liver failure Angina pectoris Myocardial infarction and heart failure Genetic heart diseases Thrombocytopenias

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Luisa Lampignano Castellana Grotte Italy 70013

    Sponsors and Collaborators

    • Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gianluigi Giannelli, Clinical Professor, Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
    ClinicalTrials.gov Identifier:
    NCT04333446
    Other Study ID Numbers:
    • 4/2020
    First Posted:
    Apr 3, 2020
    Last Update Posted:
    May 18, 2020
    Last Verified:
    May 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Obesity
    Overweight

    Study Results

    No Results Posted as of May 18, 2020